Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

Clinical trial NCT02928510 · TERMINATED

Trial details

NCT number: NCT02928510
Sponsor: Jonsson Comprehensive Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Absence of Signs or Symptoms B-Cell Non-Hodgkin Lymphoma Digestive System Signs and Symptoms Indolent Adult Non-Hodgkin Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma

Start date: 2016-02-01
Primary completion: 2018-06-05
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.